AI trial for bowel cancer care underway at 9 NHS trusts

The first UK clinical trial of an artificial intelligence (AI) device which has the potential to transform bowel cancer care is underway at nine NHS trusts. The COLO-DETECT study is trialing the use of GI Genius, an AI device which helps clinicians identify polyps during colonoscopies. Five hundred patients have already been recruited to take part in the trial at one of nine participating trusts. The AI device is capable of highlighting area that it thinks may contain a polyp – from which most bowel cancers develop. Spotting as many polyps as possible allows the area to be more closely examined to determine if polyps are present and if they need to be removed.